X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-01-23 | NTRA | Natera, Inc. | Brophy Michael Burkes | CFO | S - Sale+OE | $171.67 | -1,441 | 109,474 | -1% | -$247,378 | |||||
2025-01-22 | NTRA | Natera, Inc. | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $164.97 | -24,861 | 140,684 | -15% | -$4,101,226 | ||||||
2025-01-22 | NTRA | Natera, Inc. | Fesko John | Pres, CHIEF BUS. OFFICER | S - Sale | $164.97 | -21,228 | 147,230 | -13% | -$3,501,905 | ||||||
| D | 2025-01-22 | NTRA | Natera, Inc. | Sheena Jonathan | CO-FOUNDER | S - Sale+OE | $165.00 | -971 | 351,309 | 0% | -$160,214 | |||||
| D | 2025-01-22 | NTRA | Natera, Inc. | Rabinowitz Daniel | SEC., GC | S - Sale+OE | $164.97 | -22,039 | 217,793 | -9% | -$3,635,685 | |||||
| D | 2025-01-22 | NTRA | Natera, Inc. | Chapman Steven Leonard | CEO, Pres | S - Sale+OE | $164.97 | -78,553 | 267,629 | -23% | -$12,958,585 | |||||
| D | 2025-01-22 | NTRA | Natera, Inc. | Brophy Michael Burkes | CFO | S - Sale+OE | $164.97 | -25,931 | 109,665 | -19% | -$4,277,735 | |||||
2025-01-17 | GH | Guardant Health, Inc. | Tariq Musa | Dir | S - Sale | $37.58 | -116 | 2,944 | -4% | -$4,359 | ||||||
2025-01-13 | CSTL | Castle Biosciences Inc | Maetzold Derek J | Pres, Chief Exec. Officer | S - Sale | $28.03 | -2,565 | 381,894 | -1% | -$71,903 | ||||||
| M | 2025-01-10 | SERA | Sera Prognostics, Inc. | Phillips Joshua | Dir | S - Sale | $6.74 | -34,211 | 0 | -100% | -$230,469 | |||||
| M | 2025-01-10 | SERA | Sera Prognostics, Inc. | Jackson Benjamin | GC | S - Sale | $6.80 | -29,591 | 112,154 | -21% | -$201,133 | |||||
| M | 2025-01-10 | SERA | Sera Prognostics, Inc. | Harrison Robert Gardner | CIO | S - Sale | $7.27 | -16,473 | 114,573 | -13% | -$119,678 | |||||
2025-01-10 | SERA | Sera Prognostics, Inc. | Kearney Paul | Chief Data Officer | S - Sale | $7.42 | -13,419 | 163,470 | -8% | -$99,565 | ||||||
2025-01-10 | SERA | Sera Prognostics, Inc. | Aerts Austin | CFO | S - Sale | $8.06 | -2,431 | 283,325 | -1% | -$19,594 | ||||||
| D | 2025-01-13 | FTRE | Fortrea Holdings Inc. | Pike Thomas | CEO | S - Sale+OE | $18.04 | -11,268 | 159,868 | -7% | -$203,275 | |||||
2025-01-08 | NTRA | Natera, Inc. | Rabinowitz Daniel | SEC., GC | S - Sale | $175.30 | -6,223 | 199,804 | -3% | -$1,090,901 | ||||||
2025-01-06 | CSTL | Castle Biosciences Inc | Bradbury Daniel | Dir | S - Sale | $29.14 | -7,867 | 21,158 | -27% | -$229,226 | ||||||
| M | 2025-01-06 | CSTL | Castle Biosciences Inc | Maetzold Derek J | Pres, Chief Exec. Officer | S - Sale | $29.66 | -7,689 | 384,459 | -2% | -$228,067 | |||||
2025-01-06 | CSTL | Castle Biosciences Inc | Juvenal Tobin W | Chief Commercial Officer | S - Sale | $30.00 | -2,230 | 72,173 | -3% | -$66,900 | ||||||
2025-01-07 | LH | Labcorp Holdings Inc. | Anderson Kerrii B | Dir | S - Sale | $235.00 | -1,000 | 13,010 | -7% | -$235,000 | ||||||
2025-01-06 | SERA | Sera Prognostics, Inc. | Mirza Mansoor Raza | Dir | S - Sale | $7.69 | -100 | 6,536 | -2% | -$769 | ||||||
| D | 2025-01-02 | VCYT | Veracyte, Inc. | Eastham Karin | Dir | S - Sale+OE | $40.30 | -10,000 | 18,497 | -35% | -$403,006 | |||||
2025-01-02 | NTRA | Natera, Inc. | Sheena Jonathan | CO-FOUNDER | S - Sale | $159.50 | -5,700 | 343,936 | -2% | -$909,126 | ||||||
2024-12-23 | NTRA | Natera, Inc. | Fesko John | Pres, CHIEF BUS. OFFICER | S - Sale | $159.60 | -669 | 114,142 | -1% | -$106,773 | ||||||
2024-12-23 | NTRA | Natera, Inc. | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $159.60 | -2,428 | 116,997 | -2% | -$387,511 | ||||||
2024-12-18 | NTRA | Natera, Inc. | Sheena Jonathan | CO-FOUNDER | S - Sale | $167.25 | -5,700 | 396,414 | -1% | -$953,337 | ||||||
2024-12-18 | GH | Guardant Health, Inc. | Tariq Musa | Dir | S - Sale | $34.85 | -116 | 2,810 | -4% | -$4,043 | ||||||
2024-12-17 | CSTL | Castle Biosciences Inc | Maetzold Derek J | Pres, Chief Exec. Officer | S - Sale | $28.34 | -9,364 | 392,148 | -2% | -$265,358 | ||||||
2024-12-16 | PSNL | Personalis, Inc. | Chen Richard | Chief Medical Officer, EVP | S - Sale | $3.82 | -4,834 | 123,886 | -4% | -$18,466 | ||||||
2024-12-16 | PSNL | Personalis, Inc. | Moore Stephen Michael | SVP, GC | S - Sale | $3.82 | -1,513 | 65,875 | -2% | -$5,780 | ||||||
2024-12-16 | PSNL | Personalis, Inc. | Tachibana Aaron | CFO, COO | S - Sale | $3.82 | -6,865 | 167,098 | -4% | -$26,224 | ||||||
| M | 2024-12-13 | PMD | Psychemedics Corp | Powell Anderson Capital Partners LLC | 10% | P - Purchase | $1.91 | +159,700 | 614,406 | +35% | +$305,439 | |||||
2024-12-13 | VCYT | Veracyte, Inc. | Stapley Marc | CEO | S - Sale | $43.42 | -5,590 | 307,345 | -2% | -$242,737 | ||||||
| M | 2024-12-13 | CSTL | Castle Biosciences Inc | Maetzold Derek J | Pres, Chief Exec. Officer | S - Sale | $28.72 | -26,123 | 401,512 | -6% | -$750,296 | |||||
| D | 2024-12-13 | GH | Guardant Health, Inc. | Tariq Musa | Dir | S - Sale+OE | $35.00 | -2,320 | 2,926 | -44% | -$81,200 | |||||
2024-12-13 | NTRA | Natera, Inc. | Rabinowitz Matthew | Exec COB | S - Sale | $165.74 | -160,000 | 2,473,180 | -6% | -$26,518,750 | ||||||
| M | 2024-12-10 | PMD | Psychemedics Corp | Powell Anderson Capital Partners LLC | 10% | P - Purchase | $2.67 | +86,991 | 494,556 | +21% | +$231,849 | |||||
2024-12-10 | PMD | Psychemedics Corp | Kamin Peter | Dir, 10% | S - Sale | $2.35 | -320,708 | 1,736,741 | -16% | -$753,664 | ||||||
2024-12-10 | SERA | Sera Prognostics, Inc. | Lindgardt Zhenya | CEO | S - Sale | $7.41 | -26,224 | 793,534 | -3% | -$194,320 | ||||||
2024-12-10 | SERA | Sera Prognostics, Inc. | Aerts Austin | CFO | S - Sale | $7.41 | -5,730 | 285,756 | -2% | -$42,459 | ||||||
2024-12-10 | NTRA | Natera, Inc. | Chapman Rowan E | Dir | S - Sale | $170.24 | -1,767 | 6,202 | -22% | -$300,808 | ||||||
| D | 2024-12-09 | NTRA | Natera, Inc. | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale+OE | $166.59 | -4,858 | 114,912 | -4% | -$809,312 | |||||
| EM | 2024-08-05 | OPGN | Opgen Inc | Aei Capital Ltd | 10% | P - Purchase | $0.57 | +2,400,000 | 2,400,000 | New | +$1,367,347 | |||||
2024-12-05 | CSTL | Castle Biosciences Inc | Maetzold Derek J | Pres, Chief Exec. Officer | S - Sale | $31.35 | -5,127 | 394,713 | -1% | -$160,742 | ||||||
2024-12-06 | SERA | Sera Prognostics, Inc. | Mirza Mansoor Raza | Dir | S - Sale | $7.12 | -93 | 6,636 | -1% | -$662 | ||||||
2024-12-04 | VCYT | Veracyte, Inc. | Febbo Phillip G. | Chief Scientific, Med Officer | S - Sale | $44.09 | -3,934 | 82,414 | -5% | -$173,447 | ||||||
2024-12-04 | VCYT | Veracyte, Inc. | McGuire Annie | SVP, GC | S - Sale | $44.02 | -18,699 | 72,869 | -20% | -$823,179 | ||||||
2024-12-04 | CDNA | Caredx, Inc. | Novack Jeffrey Adam | Secretary, GC | S - Sale | $26.00 | -1,917 | 110,237 | -2% | -$49,842 | ||||||
2024-12-03 | PMD | Psychemedics Corp | Kamin Peter | Dir, 10% | P - Purchase | $2.35 | +1,409,712 | 2,057,449 | +218% | +$3,312,823 | ||||||
2024-12-03 | CSTL | Castle Biosciences Inc | Bradbury Daniel | Dir | S - Sale | $30.98 | -7,867 | 29,025 | -21% | -$243,693 | ||||||
2024-12-02 | NTRA | Natera, Inc. | Botha Roelof | Dir | S - Sale | $169.12 | -87,473 | 1,228,554 | -7% | -$14,793,563 | ||||||
2024-12-03 | VCYT | Veracyte, Inc. | Leite John | Chief Commercial Officer-CLIA | S - Sale | $43.25 | -1,050 | 73,810 | -1% | -$45,408 | ||||||
2024-12-03 | VCYT | Veracyte, Inc. | Chambers Rebecca | CFO | S - Sale | $43.23 | -7,000 | 114,037 | -6% | -$302,622 | ||||||
2024-12-03 | VCYT | Veracyte, Inc. | Wygant Jonathan | VP, Chief Accounting Officer | S - Sale | $43.36 | -956 | 40,270 | -2% | -$41,452 | ||||||
2024-12-03 | FLGT | Fulgent Genetics, Inc. | Xie Jian | Pres, COO | S - Sale | $19.50 | -1,455 | 555,497 | 0% | -$28,372 | ||||||
2024-12-03 | FLGT | Fulgent Genetics, Inc. | Gao Hanlin | Chief Scientific Officer | S - Sale | $19.50 | -1,373 | 919,469 | 0% | -$26,773 | ||||||
| D | 2024-12-02 | LH | Labcorp Holdings Inc. | Eisenberg Glenn A | EVP | S - Sale+OE | $240.43 | -11,711 | 31,289 | -27% | -$2,815,651 | |||||
2024-12-02 | LH | Labcorp Holdings Inc. | Gilliland Dwight Gary | Dir | S - Sale | $241.00 | -1,000 | 7,712 | -11% | -$241,000 | ||||||
| D | 2024-11-26 | CDNA | Caredx, Inc. | Maag Peter | Dir | S - Sale+OE | $25.00 | -5,000 | 330,024 | -1% | -$125,000 | |||||
2024-12-02 | GH | Guardant Health, Inc. | Joyce Meghan V. | Dir | S - Sale | $35.90 | -100 | 7,548 | -1% | -$3,590 | ||||||
| M | 2024-11-18 | CDNA | Caredx, Inc. | Novack Jeffrey Adam | Secretary, GC | S - Sale | $22.17 | -6,757 | 112,154 | -6% | -$149,829 | |||||
| D | 2024-11-29 | DGX | Quest Diagnostics Inc | Prevoznik Michael E | SVP, GC | S - Sale+OE | $163.07 | -35,146 | 44,096 | -44% | -$5,731,302 | |||||
| D | 2024-11-27 | DGX | Quest Diagnostics Inc | Doherty Catherine T. | EVP, Regional Businesses | S - Sale+OE | $162.99 | -33,103 | 72,804 | -31% | -$5,395,484 | |||||
2024-11-27 | VCYT | Veracyte, Inc. | Wygant Jonathan | VP, Chief Accounting Officer | S - Sale | $42.89 | -5,032 | 42,313 | -11% | -$215,834 | ||||||
| M | 2024-11-25 | NTRA | Natera, Inc. | Rabinowitz Matthew | Exec COB | S - Sale | $166.34 | -4,000 | 2,564,684 | 0% | -$665,376 | |||||
2024-11-25 | FLGT | Fulgent Genetics, Inc. | Hsieh Ming | CEO, 10% | S - Sale | $18.26 | -2,227 | 8,821,642 | 0% | -$40,663 | ||||||
2024-11-25 | FLGT | Fulgent Genetics, Inc. | Gao Hanlin | Chief Scientific Officer | S - Sale | $18.26 | -497 | 920,842 | 0% | -$9,075 | ||||||
2024-11-25 | RDNT | Radnet, Inc. | Katz David Jeffrey | EVP, GC | S - Sale | $81.65 | -12,300 | 62,909 | -16% | -$1,004,252 | ||||||
2024-11-25 | FLGT | Fulgent Genetics, Inc. | Xie Jian | Pres, COO | S - Sale | $18.26 | -689 | 556,952 | 0% | -$12,581 | ||||||
2024-11-20 | XGN | Exagen Inc. | Nmsic Co-Investment Fund, L.P. | 10% | S - Sale | $3.30 | -200,000 | 2,108,958 | -9% | -$660,040 | ||||||
| D | 2024-11-22 | LH | Labcorp Holdings Inc. | Summy Amy B. | EVP, CMO | S - Sale+OE | $238.91 | -3,672 | 4,319 | -46% | -$877,142 | |||||
2024-11-21 | LH | Labcorp Holdings Inc. | Van Der Vaart Sandra D | EVP, GC | S - Sale | $239.42 | -1,000 | 2,670 | -27% | -$239,419 | ||||||
2024-11-21 | BDSX | Biodesix Inc | Schuler Jack W | Dir, 10% | P - Purchase | $1.23 | +100,000 | 31,194,935 | 0% | +$122,840 | ||||||
2024-11-21 | BDSX | Biodesix Inc | Kennedy Lawrence T. Jr | Dir, 10% | P - Purchase | $1.16 | +35,000 | 25,454,283 | 0% | +$40,562 | ||||||
2024-11-19 | NTRA | Natera, Inc. | Marcus Gail Boxer | Dir | S - Sale | $159.98 | -9,682 | 9,704 | -50% | -$1,548,931 | ||||||
2024-11-19 | RDNT | Radnet, Inc. | Jayanathan Ranjan | CIO | S - Sale | $80.00 | -38,557 | 192,724 | -17% | -$3,084,560 | ||||||
2024-11-19 | VCYT | Veracyte, Inc. | Eastham Karin | Dir | S - Sale | $38.34 | -14,731 | 18,497 | -44% | -$564,768 | ||||||
2024-11-20 | BDSX | Biodesix Inc | Schuler Jack W | Dir, 10% | P - Purchase | $1.17 | +200,000 | 31,094,935 | +1% | +$234,000 | ||||||
2024-11-18 | PSNL | Personalis, Inc. | Tachibana Aaron | CFO, COO | S - Sale | $3.79 | -1,307 | 173,963 | -1% | -$4,954 | ||||||
2024-11-18 | PSNL | Personalis, Inc. | Moore Stephen Michael | SVP, GC | S - Sale | $3.79 | -1,693 | 67,388 | -2% | -$6,416 | ||||||
2024-11-18 | PSNL | Personalis, Inc. | Chen Richard | Chief Medical Officer, EVP | S - Sale | $3.79 | -921 | 128,720 | -1% | -$3,491 | ||||||
2024-11-15 | XGN | Exagen Inc. | Black Jeffrey G. | CFO | P - Purchase | $2.98 | +22,298 | 274,492 | +9% | +$66,448 | ||||||
2024-11-18 | GH | Guardant Health, Inc. | Kalia Kumud | CIO | S - Sale | $29.25 | -7,000 | 17,744 | -28% | -$204,722 | ||||||
2024-11-18 | GRAL | Grail, Inc. | Freidin Aaron | CFO | S - Sale | $14.02 | -30,452 | 268,277 | -10% | -$426,937 | ||||||
2024-11-15 | CSTL | Castle Biosciences Inc | Stokes Frank | CFO | S - Sale | $29.93 | -6,923 | 30,823 | -18% | -$207,217 | ||||||
2024-11-14 | XGN | Exagen Inc. | Aballi John | Pres, CEO | P - Purchase | $2.81 | +24,305 | 689,799 | +4% | +$68,297 | ||||||
| D | 2024-11-15 | NTRA | Natera, Inc. | Baynes Roy D. | Dir | S - Sale+OE | $146.11 | -37,230 | 15,807 | -70% | -$5,439,565 | |||||
2024-11-15 | NTRA | Natera, Inc. | Chapman Steven Leonard | CEO, Pres | S - Sale | $146.41 | -4,728 | 371,911 | -1% | -$692,209 | ||||||
2024-11-13 | NTRA | Natera, Inc. | Sheena Jonathan | CO-FOUNDER | S - Sale | $154.86 | -36,300 | 355,336 | -9% | -$5,621,396 | ||||||
2024-11-14 | NTRA | Natera, Inc. | Marcus Gail Boxer | Dir | S - Sale | $158.53 | -2,212 | 19,386 | -10% | -$350,672 | ||||||
2024-11-12 | CSTL | Castle Biosciences Inc | Maetzold Derek J | Pres, Chief Exec. Officer | S - Sale | $34.15 | -5,127 | 399,840 | -1% | -$175,087 | ||||||
2024-11-13 | GH | Guardant Health, Inc. | Joyce Meghan V. | Dir | S - Sale | $29.90 | -2,896 | 7,648 | -27% | -$86,595 | ||||||
| D | 2024-11-12 | GH | Guardant Health, Inc. | Clark Ian T | Dir | S - Sale+OE | $29.45 | -8,318 | 8,435 | -50% | -$244,930 | |||||
2024-11-12 | VCYT | Veracyte, Inc. | Chambers Rebecca | CFO | S - Sale | $38.34 | -15,275 | 124,501 | -11% | -$585,663 | ||||||
| D | 2024-11-12 | VCYT | Veracyte, Inc. | Epstein Robert S | Dir | S - Sale+OE | $38.32 | -15,000 | 44,598 | -25% | -$574,830 | |||||
| DM | 2024-11-11 | BDSX | Biodesix Inc | Vazquez Chris | Chief Accounting Officer | S - Sale+OE | $1.40 | -203 | 11,587 | -2% | -$283 | |||||
| DM | 2024-11-11 | BDSX | Biodesix Inc | Pestano Gary Anthony | Chief Development Officer | S - Sale+OE | $1.40 | -427 | 127,027 | 0% | -$596 | |||||
| DM | 2024-11-11 | BDSX | Biodesix Inc | O'Kane Kieran | Chief Commercial Officer | S - Sale+OE | $1.40 | -462 | 97,448 | 0% | -$645 | |||||
| DM | 2024-11-11 | BDSX | Biodesix Inc | Hutton Scott | Pres, CEO | S - Sale+OE | $1.40 | -3,740 | 532,979 | -1% | -$5,220 | |||||
| DM | 2024-11-11 | BDSX | Biodesix Inc | Cowie Robin Harper | CFO, Sec'y, Treasurer | S - Sale+OE | $1.40 | -971 | 203,336 | 0% | -$1,355 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |